世界のエスシタロプラムオキサレートAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Escitalopram Oxalate API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1143 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はエスシタロプラムオキサレートAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。エスシタロプラムオキサレートAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（エスシタロプラムオキサレート錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・エスシタロプラムオキサレートAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・エスシタロプラムオキサレートAPIの種類別市場規模：純度≥98％、純度<98％ ・エスシタロプラムオキサレートAPIの用途別市場規模：エスシタロプラムオキサレート錠、その他 ・北米のエスシタロプラムオキサレートAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのエスシタロプラムオキサレートAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのエスシタロプラムオキサレートAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のエスシタロプラムオキサレートAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのエスシタロプラムオキサレートAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Novartis、ARCH PHARMALABS LIMITED、Neuland Laboratories Ltd.、Zhejiang Huahai Pharmaceuticals Co., Ltd、Cipla、Maithili Life Sciences Private、Nishchem International Pvt. Ltd、Olon Spa、Shodhana Laboratories Ltd、Smilax Laboratories Limited ・エスシタロプラムオキサレートAPIのバリューチェーン・販売チャネル分析 ・エスシタロプラムオキサレートAPIの世界市場動向

Escitalopram Oxalate is the oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity.

Market Analysis and Insights: Global Escitalopram Oxalate API Market
The global Escitalopram Oxalate API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Escitalopram Oxalate API Scope and Segment
Escitalopram Oxalate API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Escitalopram Oxalate API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Escitalopram Oxalate Tablets Others By Company Dr. Reddy’s Laboratories Ltd. Novartis ARCH PHARMALABS LIMITED Neuland Laboratories Ltd. Zhejiang Huahai Pharmaceuticals Co., Ltd Cipla Maithili Life Sciences Private Nishchem International Pvt. Ltd Olon Spa Shodhana Laboratories Ltd Smilax Laboratories Limited Production by Region Europe India China Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Escitalopram Oxalate API Product Introduction
1.2 Market by Type
1.2.1 Global Escitalopram Oxalate API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Escitalopram Oxalate API Market Size Growth Rate by Application 1.3.2 Escitalopram Oxalate Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Escitalopram Oxalate API Production 2.1 Global Escitalopram Oxalate API Production Capacity (2016-2027) 2.2 Global Escitalopram Oxalate API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Escitalopram Oxalate API Production by Region 2.3.1 Global Escitalopram Oxalate API Historic Production by Region (2016-2021) 2.3.2 Global Escitalopram Oxalate API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 India 2.6 China 3 Global Escitalopram Oxalate API Sales in Volume & Value Estimates and Forecasts 3.1 Global Escitalopram Oxalate API Sales Estimates and Forecasts 2016-2027 3.2 Global Escitalopram Oxalate API Revenue Estimates and Forecasts 2016-2027 3.3 Global Escitalopram Oxalate API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Escitalopram Oxalate API Regions by Sales 3.4.1 Global Top Escitalopram Oxalate API Regions by Sales (2016-2021) 3.4.2 Global Top Escitalopram Oxalate API Regions by Sales (2022-2027) 3.5 Global Top Escitalopram Oxalate API Regions by Revenue 3.5.1 Global Top Escitalopram Oxalate API Regions by Revenue (2016-2021) 3.5.2 Global Top Escitalopram Oxalate API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Escitalopram Oxalate API Production Capacity by Manufacturers 4.2 Global Escitalopram Oxalate API Sales by Manufacturers 4.2.1 Global Top Escitalopram Oxalate API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Escitalopram Oxalate API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Escitalopram Oxalate API Sales in 2020 4.3 Global Escitalopram Oxalate API Revenue by Manufacturers 4.3.1 Global Top Escitalopram Oxalate API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Escitalopram Oxalate API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Escitalopram Oxalate API Revenue in 2020 4.4 Global Escitalopram Oxalate API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Escitalopram Oxalate API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Escitalopram Oxalate API Sales by Type 5.1.1 Global Escitalopram Oxalate API Historical Sales by Type (2016-2021) 5.1.2 Global Escitalopram Oxalate API Forecasted Sales by Type (2022-2027) 5.1.3 Global Escitalopram Oxalate API Sales Market Share by Type (2016-2027) 5.2 Global Escitalopram Oxalate API Revenue by Type 5.2.1 Global Escitalopram Oxalate API Historical Revenue by Type (2016-2021) 5.2.2 Global Escitalopram Oxalate API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Escitalopram Oxalate API Revenue Market Share by Type (2016-2027) 5.3 Global Escitalopram Oxalate API Price by Type 5.3.1 Global Escitalopram Oxalate API Price by Type (2016-2021) 5.3.2 Global Escitalopram Oxalate API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Escitalopram Oxalate API Sales by Application 6.1.1 Global Escitalopram Oxalate API Historical Sales by Application (2016-2021) 6.1.2 Global Escitalopram Oxalate API Forecasted Sales by Application (2022-2027) 6.1.3 Global Escitalopram Oxalate API Sales Market Share by Application (2016-2027) 6.2 Global Escitalopram Oxalate API Revenue by Application 6.2.1 Global Escitalopram Oxalate API Historical Revenue by Application (2016-2021) 6.2.2 Global Escitalopram Oxalate API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Escitalopram Oxalate API Revenue Market Share by Application (2016-2027) 6.3 Global Escitalopram Oxalate API Price by Application 6.3.1 Global Escitalopram Oxalate API Price by Application (2016-2021) 6.3.2 Global Escitalopram Oxalate API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Escitalopram Oxalate API Market Size by Type 7.1.1 North America Escitalopram Oxalate API Sales by Type (2016-2027) 7.1.2 North America Escitalopram Oxalate API Revenue by Type (2016-2027) 7.2 North America Escitalopram Oxalate API Market Size by Application 7.2.1 North America Escitalopram Oxalate API Sales by Application (2016-2027) 7.2.2 North America Escitalopram Oxalate API Revenue by Application (2016-2027) 7.3 North America Escitalopram Oxalate API Sales by Country 7.3.1 North America Escitalopram Oxalate API Sales by Country (2016-2027) 7.3.2 North America Escitalopram Oxalate API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Escitalopram Oxalate API Market Size by Type 8.1.1 Europe Escitalopram Oxalate API Sales by Type (2016-2027) 8.1.2 Europe Escitalopram Oxalate API Revenue by Type (2016-2027) 8.2 Europe Escitalopram Oxalate API Market Size by Application 8.2.1 Europe Escitalopram Oxalate API Sales by Application (2016-2027) 8.2.2 Europe Escitalopram Oxalate API Revenue by Application (2016-2027) 8.3 Europe Escitalopram Oxalate API Sales by Country 8.3.1 Europe Escitalopram Oxalate API Sales by Country (2016-2027) 8.3.2 Europe Escitalopram Oxalate API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Escitalopram Oxalate API Market Size by Type 9.1.1 Asia Pacific Escitalopram Oxalate API Sales by Type (2016-2027) 9.1.2 Asia Pacific Escitalopram Oxalate API Revenue by Type (2016-2027) 9.2 Asia Pacific Escitalopram Oxalate API Market Size by Application 9.2.1 Asia Pacific Escitalopram Oxalate API Sales by Application (2016-2027) 9.2.2 Asia Pacific Escitalopram Oxalate API Revenue by Application (2016-2027) 9.3 Asia Pacific Escitalopram Oxalate API Sales by Region 9.3.1 Asia Pacific Escitalopram Oxalate API Sales by Region (2016-2027) 9.3.2 Asia Pacific Escitalopram Oxalate API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Escitalopram Oxalate API Market Size by Type 10.1.1 Latin America Escitalopram Oxalate API Sales by Type (2016-2027) 10.1.2 Latin America Escitalopram Oxalate API Revenue by Type (2016-2027) 10.2 Latin America Escitalopram Oxalate API Market Size by Application 10.2.1 Latin America Escitalopram Oxalate API Sales by Application (2016-2027) 10.2.2 Latin America Escitalopram Oxalate API Revenue by Application (2016-2027) 10.3 Latin America Escitalopram Oxalate API Sales by Country 10.3.1 Latin America Escitalopram Oxalate API Sales by Country (2016-2027) 10.3.2 Latin America Escitalopram Oxalate API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Escitalopram Oxalate API Market Size by Type 11.1.1 Middle East and Africa Escitalopram Oxalate API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Escitalopram Oxalate API Revenue by Type (2016-2027) 11.2 Middle East and Africa Escitalopram Oxalate API Market Size by Application 11.2.1 Middle East and Africa Escitalopram Oxalate API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Escitalopram Oxalate API Revenue by Application (2016-2027) 11.3 Middle East and Africa Escitalopram Oxalate API Sales by Country 11.3.1 Middle East and Africa Escitalopram Oxalate API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Escitalopram Oxalate API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Escitalopram Oxalate API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Overview 12.2.3 Novartis Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis Escitalopram Oxalate API Product Description 12.2.5 Novartis Recent Developments 12.3 ARCH PHARMALABS LIMITED 12.3.1 ARCH PHARMALABS LIMITED Corporation Information 12.3.2 ARCH PHARMALABS LIMITED Overview 12.3.3 ARCH PHARMALABS LIMITED Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 ARCH PHARMALABS LIMITED Escitalopram Oxalate API Product Description 12.3.5 ARCH PHARMALABS LIMITED Recent Developments 12.4 Neuland Laboratories Ltd. 12.4.1 Neuland Laboratories Ltd. Corporation Information 12.4.2 Neuland Laboratories Ltd. Overview 12.4.3 Neuland Laboratories Ltd. Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Neuland Laboratories Ltd. Escitalopram Oxalate API Product Description 12.4.5 Neuland Laboratories Ltd. Recent Developments 12.5 Zhejiang Huahai Pharmaceuticals Co., Ltd 12.5.1 Zhejiang Huahai Pharmaceuticals Co., Ltd Corporation Information 12.5.2 Zhejiang Huahai Pharmaceuticals Co., Ltd Overview 12.5.3 Zhejiang Huahai Pharmaceuticals Co., Ltd Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Zhejiang Huahai Pharmaceuticals Co., Ltd Escitalopram Oxalate API Product Description 12.5.5 Zhejiang Huahai Pharmaceuticals Co., Ltd Recent Developments 12.6 Cipla 12.6.1 Cipla Corporation Information 12.6.2 Cipla Overview 12.6.3 Cipla Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Cipla Escitalopram Oxalate API Product Description 12.6.5 Cipla Recent Developments 12.7 Maithili Life Sciences Private 12.7.1 Maithili Life Sciences Private Corporation Information 12.7.2 Maithili Life Sciences Private Overview 12.7.3 Maithili Life Sciences Private Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Maithili Life Sciences Private Escitalopram Oxalate API Product Description 12.7.5 Maithili Life Sciences Private Recent Developments 12.8 Nishchem International Pvt. Ltd 12.8.1 Nishchem International Pvt. Ltd Corporation Information 12.8.2 Nishchem International Pvt. Ltd Overview 12.8.3 Nishchem International Pvt. Ltd Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Nishchem International Pvt. Ltd Escitalopram Oxalate API Product Description 12.8.5 Nishchem International Pvt. Ltd Recent Developments 12.9 Olon Spa 12.9.1 Olon Spa Corporation Information 12.9.2 Olon Spa Overview 12.9.3 Olon Spa Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Olon Spa Escitalopram Oxalate API Product Description 12.9.5 Olon Spa Recent Developments 12.10 Shodhana Laboratories Ltd 12.10.1 Shodhana Laboratories Ltd Corporation Information 12.10.2 Shodhana Laboratories Ltd Overview 12.10.3 Shodhana Laboratories Ltd Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Shodhana Laboratories Ltd Escitalopram Oxalate API Product Description 12.10.5 Shodhana Laboratories Ltd Recent Developments 12.11 Smilax Laboratories Limited 12.11.1 Smilax Laboratories Limited Corporation Information 12.11.2 Smilax Laboratories Limited Overview 12.11.3 Smilax Laboratories Limited Escitalopram Oxalate API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Smilax Laboratories Limited Escitalopram Oxalate API Product Description 12.11.5 Smilax Laboratories Limited Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Escitalopram Oxalate API Industry Chain Analysis 13.2 Escitalopram Oxalate API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Escitalopram Oxalate API Production Mode & Process 13.4 Escitalopram Oxalate API Sales and Marketing 13.4.1 Escitalopram Oxalate API Sales Channels 13.4.2 Escitalopram Oxalate API Distributors 13.5 Escitalopram Oxalate API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Escitalopram Oxalate API Industry Trends 14.2 Escitalopram Oxalate API Market Drivers 14.3 Escitalopram Oxalate API Market Challenges 14.4 Escitalopram Oxalate API Market Restraints 15 Key Finding in The Global Escitalopram Oxalate API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Escitalopram Oxalate API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Escitalopram Oxalate API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Escitalopram Oxalate API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Escitalopram Oxalate API Production by Region (2016-2021) & (Ton)
Table 7. Global Escitalopram Oxalate API Production Market Share by Region (2016-2021)
Table 8. Global Escitalopram Oxalate API Production by Region (2022-2027) & (Ton)
Table 9. Global Escitalopram Oxalate API Production Market Share by Region (2022-2027)
Table 10. Global Escitalopram Oxalate API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Escitalopram Oxalate API Sales by Region (2016-2021) & (Ton)
Table 12. Global Escitalopram Oxalate API Sales Market Share by Region (2016-2021)
Table 13. Global Escitalopram Oxalate API Sales by Region (2022-2027) & (Ton)
Table 14. Global Escitalopram Oxalate API Sales Market Share by Region (2022-2027)
Table 15. Global Escitalopram Oxalate API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Escitalopram Oxalate API Revenue Market Share by Region (2016-2021)
Table 17. Global Escitalopram Oxalate API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Escitalopram Oxalate API Revenue Market Share by Region (2022-2027)
Table 19. Global Escitalopram Oxalate API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Escitalopram Oxalate API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Escitalopram Oxalate API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Escitalopram Oxalate API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Escitalopram Oxalate API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Escitalopram Oxalate API Sales Share by Manufacturers (2016-2021)
Table 25. Global Escitalopram Oxalate API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Escitalopram Oxalate API Revenue Share by Manufacturers (2016-2021)
Table 27. Escitalopram Oxalate API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Escitalopram Oxalate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Escitalopram Oxalate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Escitalopram Oxalate API as of 2020)
Table 30. Escitalopram Oxalate API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Escitalopram Oxalate API Product Offered
Table 32. Date of Manufacturers Enter into Escitalopram Oxalate API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 35. Global Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 36. Global Escitalopram Oxalate API Sales Share by Type (2016-2021)
Table 37. Global Escitalopram Oxalate API Sales Share by Type (2022-2027)
Table 38. Global Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Escitalopram Oxalate API Revenue Share by Type (2016-2021)
Table 41. Global Escitalopram Oxalate API Revenue Share by Type (2022-2027)
Table 42. Escitalopram Oxalate API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Escitalopram Oxalate API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 45. Global Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 46. Global Escitalopram Oxalate API Sales Share by Application (2016-2021)
Table 47. Global Escitalopram Oxalate API Sales Share by Application (2022-2027)
Table 48. Global Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Escitalopram Oxalate API Revenue Share by Application (2016-2021)
Table 51. Global Escitalopram Oxalate API Revenue Share by Application (2022-2027)
Table 52. Escitalopram Oxalate API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Escitalopram Oxalate API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 55. North America Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 56. North America Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 59. North America Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 60. North America Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Escitalopram Oxalate API Sales by Country (2016-2021) & (Ton)
Table 63. North America Escitalopram Oxalate API Sales by Country (2022-2027) & (Ton)
Table 64. North America Escitalopram Oxalate API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Escitalopram Oxalate API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Escitalopram Oxalate API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Escitalopram Oxalate API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Escitalopram Oxalate API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Escitalopram Oxalate API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Escitalopram Oxalate API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Escitalopram Oxalate API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Escitalopram Oxalate API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Escitalopram Oxalate API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Escitalopram Oxalate API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Escitalopram Oxalate API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Escitalopram Oxalate API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Escitalopram Oxalate API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Escitalopram Oxalate API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Escitalopram Oxalate API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Escitalopram Oxalate API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Escitalopram Oxalate API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Escitalopram Oxalate API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Escitalopram Oxalate API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Escitalopram Oxalate API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Escitalopram Oxalate API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Escitalopram Oxalate API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Escitalopram Oxalate API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Escitalopram Oxalate API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Escitalopram Oxalate API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Escitalopram Oxalate API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Novartis Escitalopram Oxalate API Product
Table 123. Novartis Recent Development
Table 124. ARCH PHARMALABS LIMITED Corporation Information
Table 125. ARCH PHARMALABS LIMITED Description and Major Businesses
Table 126. ARCH PHARMALABS LIMITED Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. ARCH PHARMALABS LIMITED Escitalopram Oxalate API Product
Table 128. ARCH PHARMALABS LIMITED Recent Development
Table 129. Neuland Laboratories Ltd. Corporation Information
Table 130. Neuland Laboratories Ltd. Description and Major Businesses
Table 131. Neuland Laboratories Ltd. Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Neuland Laboratories Ltd. Escitalopram Oxalate API Product
Table 133. Neuland Laboratories Ltd. Recent Development
Table 134. Zhejiang Huahai Pharmaceuticals Co., Ltd Corporation Information
Table 135. Zhejiang Huahai Pharmaceuticals Co., Ltd Description and Major Businesses
Table 136. Zhejiang Huahai Pharmaceuticals Co., Ltd Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Zhejiang Huahai Pharmaceuticals Co., Ltd Escitalopram Oxalate API Product
Table 138. Zhejiang Huahai Pharmaceuticals Co., Ltd Recent Development
Table 139. Cipla Corporation Information
Table 140. Cipla Description and Major Businesses
Table 141. Cipla Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Cipla Escitalopram Oxalate API Product
Table 143. Cipla Recent Development
Table 144. Maithili Life Sciences Private Corporation Information
Table 145. Maithili Life Sciences Private Description and Major Businesses
Table 146. Maithili Life Sciences Private Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Maithili Life Sciences Private Escitalopram Oxalate API Product
Table 148. Maithili Life Sciences Private Recent Development
Table 149. Nishchem International Pvt. Ltd Corporation Information
Table 150. Nishchem International Pvt. Ltd Description and Major Businesses
Table 151. Nishchem International Pvt. Ltd Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Nishchem International Pvt. Ltd Escitalopram Oxalate API Product
Table 153. Nishchem International Pvt. Ltd Recent Development
Table 154. Olon Spa Corporation Information
Table 155. Olon Spa Description and Major Businesses
Table 156. Olon Spa Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Olon Spa Escitalopram Oxalate API Product
Table 158. Olon Spa Recent Development
Table 159. Shodhana Laboratories Ltd Corporation Information
Table 160. Shodhana Laboratories Ltd Description and Major Businesses
Table 161. Shodhana Laboratories Ltd Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Shodhana Laboratories Ltd Escitalopram Oxalate API Product
Table 163. Shodhana Laboratories Ltd Recent Development
Table 164. Smilax Laboratories Limited Corporation Information
Table 165. Smilax Laboratories Limited Description and Major Businesses
Table 166. Smilax Laboratories Limited Escitalopram Oxalate API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Smilax Laboratories Limited Escitalopram Oxalate API Product
Table 168. Smilax Laboratories Limited Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Escitalopram Oxalate API Distributors List
Table 172. Escitalopram Oxalate API Customers List
Table 173. Escitalopram Oxalate API Market Trends
Table 174. Escitalopram Oxalate API Market Drivers
Table 175. Escitalopram Oxalate API Market Challenges
Table 176. Escitalopram Oxalate API Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Escitalopram Oxalate API Product Picture
Figure 2. Global Escitalopram Oxalate API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Escitalopram Oxalate API Market Share by Application in 2020 & 2027
Figure 6. Escitalopram Oxalate Tablets
Figure 7. Others
Figure 8. Escitalopram Oxalate API Report Years Considered
Figure 9. Global Escitalopram Oxalate API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Escitalopram Oxalate API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Escitalopram Oxalate API Production Market Share by Region (2016-2021)
Figure 12. Global Escitalopram Oxalate API Production Market Share by Region (2022-2027)
Figure 13. Escitalopram Oxalate API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 14. Escitalopram Oxalate API Production Growth Rate in India (2016-2027) & (Ton)
Figure 15. Escitalopram Oxalate API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Global Escitalopram Oxalate API Sales 2016-2027 (Ton)
Figure 17. Global Escitalopram Oxalate API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Escitalopram Oxalate API Revenue 2016-2027 (US$ Million)
Figure 19. Global Escitalopram Oxalate API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 20. Global Escitalopram Oxalate API Sales Market Share by Region (2016-2021)
Figure 21. Global Escitalopram Oxalate API Sales Market Share by Region (2022-2027)
Figure 22. North America Escitalopram Oxalate API Sales YoY (2016-2027) & (Ton)
Figure 23. North America Escitalopram Oxalate API Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Europe Escitalopram Oxalate API Sales YoY (2016-2027) & (Ton)
Figure 25. Europe Escitalopram Oxalate API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Asia-Pacific Escitalopram Oxalate API Sales YoY (2016-2027) & (Ton)
Figure 27. Asia-Pacific Escitalopram Oxalate API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Latin America Escitalopram Oxalate API Sales YoY (2016-2027) & (Ton)
Figure 29. Latin America Escitalopram Oxalate API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Middle East & Africa Escitalopram Oxalate API Sales YoY (2016-2027) & (Ton)
Figure 31. Middle East & Africa Escitalopram Oxalate API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Escitalopram Oxalate API Sales in 2020
Figure 33. The Top 10 and Top 5 Players Market Share by Escitalopram Oxalate API Revenue in 2020
Figure 34. Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Global Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 36. Global Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 37. Global Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 38. Global Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 39. North America Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 40. North America Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 41. North America Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 42. North America Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 43. North America Escitalopram Oxalate API Sales Share by Country (2016-2027)
Figure 44. North America Escitalopram Oxalate API Revenue Share by Country (2016-2027)
Figure 45. United States Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 46. Canada Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 47. Europe Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 48. Europe Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 49. Europe Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 50. Europe Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 51. Europe Escitalopram Oxalate API Sales Share by Country (2016-2027)
Figure 52. Europe Escitalopram Oxalate API Revenue Share by Country (2016-2027)
Figure 53. Germany Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 54. France Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 55. U.K. Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 56. Italy Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 57. Russia Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 58. Asia Pacific Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 59. Asia Pacific Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 60. Asia Pacific Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 61. Asia Pacific Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 62. Asia Pacific Escitalopram Oxalate API Sales Share by Region (2016-2027)
Figure 63. Asia Pacific Escitalopram Oxalate API Revenue Share by Region (2016-2027)
Figure 64. China Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 65. Japan Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 66. South Korea Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 67. India Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 68. Australia Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 69. China Taiwan Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 70. Indonesia Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 71. Thailand Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 72. Malaysia Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 73. Latin America Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 74. Latin America Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 75. Latin America Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 76. Latin America Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 77. Latin America Escitalopram Oxalate API Sales Share by Country (2016-2027)
Figure 78. Latin America Escitalopram Oxalate API Revenue Share by Country (2016-2027)
Figure 79. Mexico Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 80. Brazil Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 81. Argentina Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 82. Middle East and Africa Escitalopram Oxalate API Sales Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Escitalopram Oxalate API Revenue Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Escitalopram Oxalate API Sales Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Escitalopram Oxalate API Revenue Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Escitalopram Oxalate API Sales Share by Country (2016-2027)
Figure 87. Middle East and Africa Escitalopram Oxalate API Revenue Share by Country (2016-2027)
Figure 88. Turkey Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 89. Saudi Arabia Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 90. UAE Escitalopram Oxalate API Revenue (2016-2027) & (US$ Million)
Figure 91. Escitalopram Oxalate API Value Chain
Figure 92. Escitalopram Oxalate API Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---